share_log

HC Wainwright & Co. Reiterates Buy on ANI Pharmaceuticals, Maintains $94 Price Target

Benzinga ·  Sep 17 18:24  · Ratings

HC Wainwright & Co. analyst Oren Livnat reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $94 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment